ACTIVE SUBSTANCE / INN

PANTOPRAZOLE SODIUM

Brand name(s): PROTONIX IV, PANTOPRAZOLE SODIUM, PROTONIX, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
NDA020988
NDA217512
ACTIVE SUBSTANCE
Pantoprazole Sodium
REGULATORS
FDA
SPONSORS / MAH
TEVA PARENTERAL, BAXTER HLTHCARE CORP, L PERRIGO CO
TOTAL APPLICATIONS
6
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
PANTOPRAZOLE SODIUMANDA204400GLANDPrescription
PROTONIXNDA020987WYETH PHARMSPrescription
PANTOPRAZOLE SODIUMANDA203024L PERRIGO CODiscontinued
PANTOPRAZOLE SODIUMNDA022226TEVA PARENTERALNone (Tentative Approval)
PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDENDA217512BAXTER HLTHCARE CORPPrescription
PROTONIX IVNDA020988WYETH PHARMSPrescription

FULL INTELLIGENCE ON PANTOPRAZOLE SODIUM

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →